- Profile
- Personal Information
- Publications
Experts in General Science
Cheng-Li Liu Miguel Acevedo Faramarz Helali Peter Andreas In-Ju Kim Rabiul Ahasan Anil K. Tripathi Isamu Nishida Gregor Harih Stoica George Tal Amasay Brian Rothman Semra Peksoz Ashok Sharma Mahesh Kumar Vyas Arjunsingh Baghel Calatayud Paul Andre MARCO ADAMINA Heba Barazi AEBERSOLD URSULA View MoreDirk Beher (Ph.D.)
Chief Executive Officer
Administration Board
ASCENEURON
Switzerland
Dirk Beher is the Chief Executive Officer, a Founder and a Member of the Board of Directors of Asceneuron SA. Since its inception he has strategically positioned Asceneuron as an emerging leader in the field of orally bioavailable drugs for treating tauopathies. Under his leadership the company has raised to date over CHF 40 million from leading venture capital firms and successfully moved a novel modifier of tau pathology into the clinic. Dirk brings more than 25 years of experience in the field of Alzheimer's disease / neurodegeneration and spent over 19 years in pharmaceutical drug discovery including senior research positions around the globe at Merck Sharp & Dohme (Merck & Co.), Amgen and Merck KGaA. Dirk holds a Ph.D. and a Diploma (M.S.) in Biology from the Ruprecht-Karls University Heidelberg, Germany. He is an inventor of seven patents and author of 49 peer-reviewed publications and reviews.
Alzheimer's disease / neurodegeneration